Parathyroid cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
The incidence of parathyroid cancer is approximately 0.015 per 100,000 individuals in United States. | The incidence of parathyroid cancer is approximately 0.015 per 100,000 individuals in United States. Parathyroid cancer affects men and women equally. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
Revision as of 17:58, 23 December 2015
|
Parathyroid cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parathyroid cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Parathyroid cancer epidemiology and demographics |
|
Parathyroid cancer epidemiology and demographics in the news |
|
Risk calculators and risk factors for Parathyroid cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
The incidence of parathyroid cancer is approximately 0.015 per 100,000 individuals in United States. Parathyroid cancer affects men and women equally.
Epidemiology and Demographics
Prevalence
- In developed countries, the prevalence of parathyroid cancer in United States estimated to be .005%
Incidence
- In developed countries, the incidence of parathyroid cancer is 0.015 per 100,000 individuals.
Age
- The median age in most series is between 45 and 51 years.
Gender
- The ratio of affected female to maile is 1:1.
Developed Countries
- In Europe, the United States, and Japan, parathyroid carcinoma has been estimated to cause hyperparathyroidism (HPT) in .017% to 5.2% of the cases; however, many series report this entity to account for less than 1% of patients with primary HPT